These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2529321)

  • 1. Effects of nicotinic acid, nicotinamide, and pyridylcarbinol in pharmacological dosages on lipid metabolism in humans.
    Zöllner N
    Int J Vitam Nutr Res Suppl; 1989; 30():114-9. PubMed ID: 2529321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of a retard preparation of beta-pyridylcarbinol using a new automated assay method].
    Schräpler P; Schulz E; Scholer A
    Med Welt; 1977 Nov; 28(46):1900-3. PubMed ID: 593135
    [No Abstract]   [Full Text] [Related]  

  • 3. Release of disaggregatory prostanoids into circulation by nicotinic alcohol, nicotinic acid and nicotinamide.
    Swies J; Dabrowski L
    Pol J Pharmacol Pharm; 1984; 36(6):653-7. PubMed ID: 6242066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte deformability improving action of beta-pyridylcarbinol tartrate.
    Okada T; Okamoto A; Nakamura K
    Experientia; 1981; 37(8):890-2. PubMed ID: 7286147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on beta-pyridylcarbinol as a precursor of nicotinamide adenine dinucleotide.
    Kizu A; Nakamura T; Kato S; Sawada K; Ijichi H; Kuriyama K
    Jpn J Pharmacol; 1977 Dec; 27(6):817-21. PubMed ID: 204821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the activity of liver NADase in rats after administration of nicotinic acid, 3-methylpyridine and nicotinamide in excess].
    Chagovets RV; Khalmuradov AG; Shushevich SI
    Dokl Akad Nauk SSSR; 1968 Jul; 181(1):245-7. PubMed ID: 4315740
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihyperlipidemic properties of beta-pyridylcarbinol. A review of preclinical studies.
    Cohen M
    Life Sci; 1985 Nov; 37(21):1949-61. PubMed ID: 3906330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Pyridylcarbinol (Ronicol) releases a prostacyclin-like substance into arterial blood of patients with arteriosclerosis obliterans.
    Dembińska-Kieć A; Korbut R; Bierón K; Kostka-Trabka E; Gryglewski RJ
    Pharmacol Res Commun; 1983 Apr; 15(4):377-85. PubMed ID: 6346344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-pyridylcarbinol (Ronicol) on the myocardial contractility in normal persons.
    Aigner A; Bolzano K; Lisch HJ; Sailer S
    Atherosclerosis; 1974; 20(1):23-5. PubMed ID: 4617580
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of high doses of nicotinic acid and its derivatives on free fatty acids in the blood of rats].
    Mainardi L; Bissanti A; Tenconi LT
    Acta Vitaminol Enzymol; 1967; 21(3):87-92. PubMed ID: 4228428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interaction of muscle glycogen phosphorylase b with nicotinic acid, nicotinamide, N-nicotinyl-gamma-aminobutyric acid and nicotinamide coenzymes].
    Klinova NI; Chebotareva NA; Klinov SV; Kurganov BI; Bulanova LN
    Bioorg Khim; 1987 Oct; 13(10):1338-43. PubMed ID: 2963642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of yeast glyceraldehyde-3-phosphate dehydrogenase by nicotinic and quinolinic acid derivatives].
    Smirnova IN; Ianina MM; Mal'tsev NI; Nagradova NK
    Dokl Akad Nauk SSSR; 1973; 210(6):1471-3. PubMed ID: 4269107
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential hypolipidemic agents. XIII. Synthesis and plasma lipid-lowering properties of some acetals derived from 3-pyridylmethanol or nicotinaldehyde.
    Bondesson G; Hedbom C; Magnusson O; Stjernström NE
    Acta Pharm Suec; 1976; 13(1):1-8. PubMed ID: 1258658
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of nicotinic alcohol therapy on serum lipoproteins in patients with hyperbetalipoproteinemia].
    Zanaboni L; Sommariva D; Bonfiglioli D; Fasoli A
    Clin Ter; 1983 Jun; 105(6):487-91. PubMed ID: 6617111
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of nicotinamide and nicotinic acid to hypolipidemia.
    Dalton C; VanTrabert TC; Dwyer JX
    Biochem Pharmacol; 1970 Sep; 19(9):2609-19. PubMed ID: 4249087
    [No Abstract]   [Full Text] [Related]  

  • 16. The sensitivity of Staphylococcus aureus 79 and 80, and Escherichia coli 95 to sodium salicylate, nicotinaldehyde singly, and in combination with nicotinic acid or nicotinamide.
    Kaplan D
    Chemotherapy; 1979; 25(6):346-51. PubMed ID: 160304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of high doses of nicotinic acid and its derivatives on blood sugar in the rat].
    Mainardi L; Tenconi LT
    Acta Vitaminol Enzymol; 1967; 21(1):31-5. PubMed ID: 4229109
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of hypercholesterolemia with beta-pyridylcarbinol. Part 5. Report on 16 cases with severe hypercholesterolemia treated for 12 years.
    Zöllner N; Keller CH; Wolfram G
    Atherosclerosis; 1977 Apr; 26(4):611-5. PubMed ID: 856228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of the antilipemic action of niacin].
    Vinogradov VV; Mandrik KA; Tarasov IuA; Strumilo SA; Matsiuk SK
    Vopr Pitan; 1978; (1):36-40. PubMed ID: 146967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical mechanism of action of nicotinic acid, nicotinamide, methionine and D-penicillamine in treatment of psychoses].
    Kanig K
    Arzneimittelforschung; 1970 Jul; 20(7):909-11. PubMed ID: 4248467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.